OTCMKTS:BMXMF - BioMerieux Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $75.31 -0.19 (-0.25 %) (As of 11/16/2018 04:00 PM ET)Previous Close$75.31Today's Range$74.7250 - $75.3152-Week Range$72.51 - $96.25Volume106 shsAverage VolumeN/AMarket CapitalizationN/AP/E Ratio33.03Dividend YieldN/ABetaN/A ProfileDiscussionChartHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email bioMérieux S.A. provides vitro diagnostic solutions systems for private and hospital laboratories, primarily for the diagnosis of infectious diseases. The company offers microbiology technology that involves culturing biological samples; and immunoassays technology based on antigen-antibody reaction, detects and measures infectious agents, such as bacteria, viruses, and parasites, as well as measures the specific biomarkers of various pathologies, such as metabolic, hormonal, infectious, etc. It also provides molecular biology for the detection of genetic sequences of deoxyribonucleic acid or ribonucleic acid; and companion diagnostic test based on biomarkers, as well as services for clinical and industrial laboratories. The company was formerly known as B-D Mérieux. bioMérieux S.A. was founded in 1963 and is based in Marcy l'Etoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA. Receive BMXMF News and Ratings via Email Sign-up to receive the latest news and ratings for BMXMF and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Private households Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:BMXMF Previous Symbol CUSIPN/A Webwww.biomerieux.com Phone33-4-78-87-20-00 Debt Debt-to-Equity Ratio0.22 Current Ratio1.99 Quick Ratio1.30 Price-To-Earnings Trailing P/E Ratio33.03 Forward P/E Ratio30.49 P/E GrowthN/A Sales & Book Value Annual Sales$2.58 billion Price / Sales3.45 Cash FlowN/A Price / CashN/A Book Value$16.58 per share Price / Book4.54 Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/A Miscellaneous Employees10,800 Outstanding Shares118,360,000Market Cap$0.00 OptionableNot Optionable BioMerieux (OTCMKTS:BMXMF) Frequently Asked Questions What is BioMerieux's stock symbol? BioMerieux trades on the OTCMKTS under the ticker symbol "BMXMF." Has BioMerieux been receiving favorable news coverage? News coverage about BMXMF stock has trended neutral this week, InfoTrie Sentiment Analysis reports. The research group scores the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. BioMerieux earned a coverage optimism score of 0.2 on InfoTrie's scale. They also gave news articles about the company a news buzz of 10.0 out of 10, meaning that recent news coverage is extremely likely to have an effect on the company's share price in the next few days. Who are some of BioMerieux's key competitors? Some companies that are related to BioMerieux include AMS AG/ADR (AMSSY), Aurora Cannabis (ACBFF), Brain Resource (BRRZY), FUCHS PETROLUB/ADR (FUPBY), Hitachi Kokusai Electric (HTKKY), KAO (KCRPY), KIMBERLY CLARK/ADR (KCDMY), Kobe Steel (KBSTY), Ladbrokes Coral (LDCOY), Obayashi (OBYCF), SSP Group (SSPPF), Std Lf PLC/ADR (SLFPY), SYMRISE AG/ADR (SYIEY), Wentworth Resource (WENTF) and WIRECARD AG/ADR (WCAGY). Who are BioMerieux's key executives? BioMerieux's management team includes the folowing people: Mr. Alexandre Mérieux, Chairman & CEO (Age 44)Mr. Guillaume Bouhours, Exec. VP & CFO (Age 42)Sylvain Morgeau, Investor RelationsMr. Michel Baguenault, Exec. VP of HR & Communications and Company Sec.Ms. Claire Giraut, Chief Financial Officer and Corp. VP (Age 62) How do I buy shares of BioMerieux? Shares of BMXMF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is BioMerieux's stock price today? One share of BMXMF stock can currently be purchased for approximately $75.31. What is BioMerieux's official website? The official website for BioMerieux is http://www.biomerieux.com. How can I contact BioMerieux? BioMerieux's mailing address is 376 CHEMIN DE L`ORME, MARCY L`ETOILE I0, 69280. The company can be reached via phone at 33-4-78-87-20-00 or via email at [email protected] MarketBeat Community Rating for BioMerieux (OTCMKTS BMXMF)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 53 (Vote Outperform)Underperform Votes: 55 (Vote Underperform)Total Votes: 108MarketBeat's community ratings are surveys of what our community members think about BioMerieux and other stocks. Vote "Outperform" if you believe BMXMF will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BMXMF will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/17/2018 by MarketBeat.com StaffFeatured Article: How does inflation affect different investments?